Aventis Pharma Holdings Limited

Active03835646 Private limited company
Incorporated
3 September 1999 (27 years)
Industry
Activities of other holding companies n.e.c. (64209)
Directors
Owned by
Sanofi
Accounts type
Full
Region
South East
Address
410 Thames Valley Park Drive
Reading
RG6 1PT

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
14 January 2027
Last conf. stmt
31 December 2025

Officers 2 active

Officer details are public data from the Companies House register.

Director · Appointed 1 February 2026
Also at Blueprint Medicines (UK) Ltd., Fisons Limited, Rhone-Poulenc Rorer Limited · more companies
Egyptian
Born October 1977 (49)
Director · Appointed 1 February 2026
Also at Genzyme Therapeutics Limited, RPR (US) Limited, Aventis Pharma Limited · more companies
Egyptian
Born August 1984 (42)
Officer history (21 former)
1 February 2026
Resigned Khan, Usman as Director
1 February 2026
Appointed Mohamed, Walaa Mostafa Abbas Awad as Director
1 February 2026
Resigned Ubhi, Rippondeep as Director
1 February 2026
Appointed Moussa, Ahmed Mohamed Moustafa as Director
1 March 2024
Appointed Ubhi, Rippondeep as Director
1 March 2024
Resigned Baird, Jessamy Rachel as Director
19 August 2021
Appointed Baird, Jessamy Rachel as Director
19 August 2021
Resigned Tillett, Gordon Michael as Director
31 March 2021
Appointed Khan, Usman as Director
31 March 2021
Appointed Tillett, Gordon Michael as Director
31 March 2021
Resigned Fry, Hugo Rupert Alexander as Director
31 March 2021
Resigned Duhalde, Francois-Xavier as Director
1 January 2017
Appointed Fry, Hugo Rupert Alexander as Director
30 September 2016
Resigned Stenvall, Tarja Johanna as Director
1 April 2016
Appointed Duhalde, Francois-Xavier as Director
1 April 2016
Resigned Prosser, Andrew Michael James as Director
19 November 2014
Appointed Stenvall, Tarja Johanna as Director
25 July 2014
Resigned Oldfield, Stephen Philip as Director
1 October 2010
Resigned Mcclellan, Michael James as Director
1 September 2010
Appointed Prosser, Andrew Michael James as Director
7 June 2010
Appointed Oldfield, Stephen Philip as Director
7 June 2010
Resigned Mcclellan, Michael James as Secretary
7 June 2010
Resigned Brooksby, Nigel Stanley as Director
13 February 2008
Appointed Mcclellan, Michael James as Secretary
30 January 2008
Resigned Roberts, Helen as Secretary
16 November 2007
Appointed Mcclellan, Michael James as Director
16 November 2007
Resigned De Forceville, Guillaume Adrien as Director
20 December 2004
Appointed Roberts, Helen as Secretary
20 December 2004
Resigned Nicholls, David John as Secretary
8 November 2004
Appointed Brooksby, Nigel Stanley as Director
8 November 2004
Resigned Rees, David Hugh Thomas as Director
8 November 2004
Appointed De Forceville, Guillaume Adrien as Director
8 November 2004
Resigned Nicholls, David John as Director
13 December 2002
Resigned Mitchum, James Paul as Director
2 December 2002
Appointed Rees, David Hugh Thomas as Director
30 June 2001
Appointed Nicholls, David John as Secretary
30 June 2001
Resigned Clapham, Christopher Edward as Secretary
8 December 2000
Appointed Clapham, Christopher Edward as Secretary
8 December 2000
Appointed Nicholls, David John as Director
8 December 2000
Appointed Mitchum, James Paul as Director
8 December 2000
Resigned Mawlaw Secretaries Limited as Corporate Secretary
8 December 2000
Resigned Mawlaw Corporate Services Limited as Corporate Director
3 September 1999
Appointed Mawlaw Secretaries Limited as Corporate Secretary
3 September 1999
Appointed Mawlaw Corporate Services Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Sanofi
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
French Corporation

Group structure 7 companies

Ownership group derived from the Companies House PSC register

Aventis Pharma Holdings Limited This company
Sanofi-Aventis Pensions Trust Limited Owns 75–100% of shares
Sanofi-Aventis UK Holdings Limited Owns 50–75% of shares
Aventis Pharma Limited Owns 75–100% of shares
Fisons Limited Owns 75–100% of shares
Genzyme Therapeutics Limited Owns 75–100% of shares
May & Baker Limited Owns 75–100% of shares

Filings 147

DateDescriptionMade Up ToPagesPDF
11 August 2026Full accounts31 December 2025
5 February 2026Appointment of a director
5 February 2026Appointment of a director
5 February 2026Termination of appointment of a director
5 February 2026Termination of appointment of a director
Show all 147 filings

Some other companies at this address

Aventis Pharma Limited
Fisons Limited
Genzyme Therapeutics Limited
May & Baker Limited
Opal Holdco 1.5 Limited
Opal Holdco 2 Limited

Other companies in this industry

London
Woking
Leicester
Surbiton
London
Chippenham

By trade and location

New companies in Reading →

Explore the largest companies

Largest companies in Reading, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?